Xepi is indicated for the topical treatment of impetigo due to S. aureus or S. pyogenes in adult and pediatric patients. The Food and Drug Administration (FDA) has approved Xepi (ozenoxacin cream; ...
Reviews of Infectious Diseases, Vol. 9, Supplement 5. Perspectives on Bacterial Pathogenesis and Host Defense (Sep. - Oct., 1987), pp. S475-S481 (7 pages) It is now recognized that bacteria bind to ...
Topical treatment of impetigo due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes in patients ≥9 months of age. Altabax contains retapamulin, a semisynthetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback